282893234	282893234	CD	B-NP	O
|	|	NN	I-NP	O
LCH	LCH	NN	I-NP	O
|	|	NN	I-NP	O
00497338	00497338	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9139125	9139125	CD	B-NP	O
|	|	CC	I-NP	O
11/10/2006	11/10/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHEST	CHEST	NNP	I-NP	I-protein
PAIN	PAIN	NNP	I-NP	I-protein
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/10/2006	11/10/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/16/2007	1/16/2007	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
PAAVOLA	PAAVOLA	NNP	B-NP	O
,	,	,	O	O
OMAR	OMAR	NNP	B-NP	O
MD	MD	NNP	I-NP	O
ADMITTING	ADMITTING	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
81-year-old	81-year-old	JJ	I-NP	O
Italian-speaking	Italian-speaking	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
COPD	COPD	NN	B-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
with	with	IN	B-PP	O
rise	rise	NN	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
PE	PE	NN	I-NP	O
protocol	protocol	NN	I-NP	O
was	be	VBD	B-VP	O
reportedly	reportedly	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
.	.	.	O	O

Several	Several	JJ	B-NP	O
hours	hour	NNS	I-NP	O
later	later	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
left-sided	left-sided	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
with	with	IN	B-PP	O
ST	ST	JJ	B-NP	O
elevations	elevation	NNS	I-NP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	O
,	,	,	O	O
V4	V4	NN	B-NP	B-protein
and	and	CC	O	O
enzyme	enzyme	NN	B-NP	O
leak	leak	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
11/27/06	11/27/06	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
M	M	NNP	B-NP	O
Valley	Valley	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
three-vessel	three-vessel	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hyperglyceridemia	Hyperglyceridemia	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

COPD	COPD	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

BPH	BPH	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Seizures	Seizure	NNS	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Blindness	Blindness	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
eye	eye	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Bilateral	Bilateral	JJ	B-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Right	Right	RB	B-ADVP	O
knee	knee	VB	B-VP	O
re-operated	re-operated	JJ	B-ADJP	O
for	for	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Bilateral	Bilateral	JJ	B-NP	O
inguinal	inguinal	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Right	Right	NN	B-NP	O
eye	eye	NN	I-NP	O
enucleation	enucleation	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Italian	Italian	JJ	B-NP	O
speaking	speaking	NN	I-NP	O
,	,	,	O	O
lives	live	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
accompanied	accompany	VBN	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
son	son	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
retired	retired	JJ	I-NP	O
farm	farm	NN	I-NP	O
worker	worker	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
allergic	allergic	JJ	B-ADJP	O
to	to	TO	B-PP	O
Ciprofloxacin	Ciprofloxacin	NN	B-NP	O
,	,	,	O	O
Ceftin	Ceftin	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
Singulair	Singulair	NNP	B-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	O
25	25	CD	I-NP	O
orally	orally	RB	B-NP	O
every	every	DT	I-NP	O
6	6	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Diltiazem	Diltiazem	NN	B-NP	O
125	125	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Furosemide	Furosemide	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Methylprednisolone	Methylprednisolone	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	I-NP	O
every	every	DT	B-NP	O
8	8	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Atorvastatin	Atorvastatin	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Allopurinol	Allopurinol	DT	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Ativan	Ativan	IN	B-PP	O
0.5	0.5	CD	B-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Proscar	Proscar	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
every	every	DT	B-NP	O
night	night	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
.	.	.	O	O

Temperature	Temperature	NN	B-NP	B-protein
97.1	97.1	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
73	73	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	B-DNA
arm	arm	NN	I-NP	I-DNA
108/59	108/59	CD	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
,	,	,	O	O
PERRLA	PERRLA	NN	B-NP	O
,	,	,	O	O
dentition	dentition	NN	B-NP	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
chest	chest	NN	B-NP	O
examination	examination	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
incisions	incision	NNS	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
,	,	,	I-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
without	without	IN	B-PP	O
murmurs	murmur	NNS	B-NP	O
.	.	.	O	O

Respiratory	Respiratory	JJ	B-ADJP	O
,	,	,	O	O
breath	breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
inguinal	inguinal	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
incisions	incision	NNS	I-NP	O
and	and	CC	O	O
enlarged	enlarged	JJ	B-NP	O
right	right	JJ	I-NP	O
groin	groin	NN	I-NP	O
hematoma	hematoma	NN	I-NP	O
from	from	IN	B-PP	O
previous	previous	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
extremities	extremity	NNS	B-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
varicosities	varicosity	NNS	I-NP	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
without	without	IN	B-PP	O
focal	focal	JJ	B-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
performed	perform	VBN	B-VP	O
at	at	IN	B-PP	O
An	An	DT	B-NP	O
on	on	IN	B-PP	O
11/2/06	11/2/06	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
mid	mid	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
,	,	,	O	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
distal	distal	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
,	,	,	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
ostial	ostial	JJ	I-NP	O
OM1	OM1	NN	I-NP	O
,	,	,	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
mid	mid	JJ	I-NP	O
CX	CX	NN	I-NP	O
,	,	,	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
mid	mid	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
mid	mid	JJ	I-NP	O
LM	LM	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
on	on	IN	B-PP	O
5/5/06	5/5/06	CD	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
76	76	CD	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
incomplete	incomplete	JJ	I-NP	O
right	right	JJ	I-NP	O
bundle-branch	bundle-branch	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
chest	ch	JJS	I-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
on	on	IN	B-PP	O
11/2/06	11/2/06	CD	B-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
is	be	VBZ	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
by	by	IN	B-PP	O
systems	system	NNS	B-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
:	:	:	O	O
Agitation	Agitation	NN	B-NP	O
and	and	CC	I-NP	O
delirium	delirium	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
immediate	immediate	JJ	I-NP	O
postoperative	postoperative	JJ	I-NP	O
period	period	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
alcohol	alcohol	NN	B-NP	O
drip	drip	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
a	a	DT	B-NP	O
preop	preop	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
alcohol	alcohol	NN	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
neurologic	neurologic	JJ	I-NP	O
status	status	NN	I-NP	O
improved	improve	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
being	be	VBG	B-VP	O
more	more	RBR	B-ADJP	O
alert	alert	JJ	I-ADJP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
with	with	IN	B-PP	O
family	family	NN	B-NP	O
members	member	NNS	I-NP	O
present	present	VBP	B-VP	O
.	.	.	O	O

Haldol	Haldol	NN	B-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
p.r.n.	p.r.n.	NN	B-NP	O
for	for	IN	B-PP	O
agitation	agitation	NN	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
11/27/06	11/27/06	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	graft	VBG	B-VP	O
x1	x1	NN	B-NP	O
with	with	IN	B-PP	O
LIMA	LIMA	NN	B-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
incomplete	incomplete	JJ	B-NP	O
revascularization	revascularization	NN	I-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
inadequate	inadequate	JJ	B-NP	O
conduit	conduit	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
observation	observation	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Cardiac	Cardiac	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
,	,	,	O	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
beta-blockers	beta-blocker	NNS	B-NP	O
and	and	CC	I-NP	O
statins	statin	NNS	I-NP	O
.	.	.	O	O

Later	Later	RB	B-ADVP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
became	become	VBD	B-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
,	,	,	O	O
requiring	require	VBG	B-VP	O
fluid	fluid	NN	B-NP	O
resuscitation	resuscitation	NN	I-NP	O
and	and	CC	O	O
vasopressor	vasopressor	NN	B-NP	O
administration	administration	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Respiratory	Respiratory	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
two	two	CD	I-NP	O
,	,	,	O	O
but	but	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
reintubated	reintubate	VBN	I-VP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
failure	failure	NN	I-NP	O
later	later	RB	B-ADVP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
with	with	IN	B-PP	O
subsequent	subsequent	JJ	B-NP	O
re-extubation	re-extubation	NN	I-NP	O
on	on	IN	B-PP	O
2/16/07	2/16/07	CD	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
two	two	CD	B-NP	O
additional	additional	JJ	I-NP	O
re-intubations	re-intubation	NNS	I-NP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
failure	failure	NN	I-NP	O
events	event	NNS	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
on	on	IN	B-PP	O
11/21/07	11/21/07	CD	B-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
extubation	extubation	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
11/17/07	11/17/07	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
one	one	CD	I-NP	O
on	on	IN	B-PP	O
4/18/07	4/18/07	CD	B-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
extubation	extubation	NN	B-NP	O
on	on	IN	B-PP	O
3/23/07	3/23/07	CD	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
nutrition	nutrition	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
soft	soft	JJ	B-NP	O
mechanical	mechanical	JJ	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
intake	intake	NN	I-NP	O
was	be	VBD	B-VP	O
limited	limit	VBN	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
puff	puff	NN	I-NP	O
tubes	tube	NNS	I-NP	O
were	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
multiple	multiple	JJ	B-NP	O
times	time	NNS	I-NP	O
for	for	IN	B-PP	O
additional	additional	JJ	B-NP	O
nutrition	nutrition	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
were	be	VBD	B-VP	O
frequently	frequently	RB	I-VP	O
removed	remove	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
delirium	delirium	NN	I-NP	O
and	and	CC	I-NP	O
agitation	agitation	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
good	good	JJ	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
electrolyte	electrolyte	NN	I-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
closely	closely	RB	I-VP	O
monitored	monitor	VBN	I-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
Tight	Tight	NN	B-NP	O
glycemic	glycemic	JJ	I-NP	O
control	control	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
with	with	IN	B-PP	O
Portland	Portland	NNP	B-NP	O
protocol	protocol	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
immediate	immediate	JJ	I-NP	O
postop	postop	JJ	I-NP	O
period	period	NN	I-NP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-ADVP	O
with	with	IN	B-PP	O
subcu	subcu	NN	B-NP	O
insulin	insulin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
preop	preop	JJ	I-NP	O
indications	indication	NNS	I-NP	O
for	for	IN	B-PP	O
COPD	COPD	NN	B-NP	O
and	and	CC	O	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
postop	postop	JJ	I-NP	O
frequent	frequent	JJ	I-NP	O
bronchospastic	bronchospastic	JJ	I-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Hematologic	Hematologic	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	B-PP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
Plavix	Plavix	NNP	B-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
incomplete	incomplete	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
vascularization	vascularization	NN	I-NP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	O
and	and	CC	I-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
:	:	:	O	O
A	A	DT	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
Sternal	Sternal	JJ	I-NP	O
wound	wound	NN	I-NP	O
infection	infection	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
pericardial	pericardial	JJ	B-NP	O
strip	strip	NN	I-NP	O
advancement	advancement	NN	I-NP	O
on	on	IN	B-PP	O
11/21/07	11/21/07	CD	B-NP	O
and	and	CC	O	O
omental	omental	JJ	B-NP	O
flap	flap	NN	I-NP	O
and	and	CC	I-NP	O
wound	wound	NN	I-NP	O
closure	closure	NN	I-NP	O
on	on	IN	B-PP	O
10/1/07	10/1/07	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
wound	wound	NN	I-NP	O
was	be	VBD	B-VP	O
reopened	reopen	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bedside	bedside	NN	I-NP	O
on	on	IN	B-PP	O
7/28/07	7/28/07	CD	B-NP	O
by	by	IN	B-PP	O
Plastic	Plastic	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
increased	increase	VBN	B-NP	O
drainage	drainage	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
VAC	VAC	NN	I-NP	O
sponge	sponge	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

Wound	Wound	JJ	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
appropriate	appropriate	JJ	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
was	be	VBD	B-VP	O
instituted	institute	VBN	I-VP	O
.	.	.	O	O

B	B	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pneumonias	Pneumonias	NNP	I-NP	O
.	.	.	O	O

Treated	Treat	VBN	B-VP	O
initially	initially	RB	B-ADVP	O
empirically	empirically	RB	B-ADVP	O
and	and	CC	I-ADVP	O
subsequently	subsequently	RB	I-ADVP	O
with	with	IN	B-PP	O
specific	specific	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
after	after	IN	B-PP	O
culture	culture	NN	B-NP	O
results	result	NNS	I-NP	O
became	become	VBD	B-VP	O
available	available	JJ	B-ADJP	O
.	.	.	O	O

C	C	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Fever	Fever	NNP	I-NP	O
,	,	,	O	O
later	later	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
experienced	experience	VBD	B-VP	O
fever	fever	NN	B-NP	O
without	without	IN	B-PP	O
leukocytosis	leukocytosis	NN	B-NP	B-cell_line
despite	despite	IN	B-PP	I-cell_line
negative	negative	JJ	B-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
.	.	.	O	O

Throughout	Throughout	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
Infectious	Infectious	NNP	B-NP	O
Disease	Disease	NNP	I-NP	O
Service	Service	NNP	I-NP	O
and	and	CC	O	O
Pulmonary	Pulmonary	NNP	B-NP	O
Service	Service	NNP	I-NP	O
were	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
followed	follow	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continuously	continuously	RB	B-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Other	Other	JJ	B-ADJP	O
:	:	:	O	O
Incidental	Incidental	JJ	B-NP	O
radiologic	radiologic	JJ	I-NP	O
finding	finding	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
mass	mass	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
renal	renal	JJ	B-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
.	.	.	O	O

Urology	Urology	NNP	B-NP	O
Service	Service	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
recommendations	recommendation	NNS	I-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
for	for	IN	B-PP	O
no	no	DT	B-NP	O
intervention	intervention	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
excessive	excessive	JJ	B-NP	O
discussion	discussion	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
very	very	RB	I-NP	B-protein
supportive	supportive	JJ	I-NP	I-protein
patient	patient	NN	I-NP	I-protein
's	's	POS	B-NP	I-protein
family	family	NN	I-NP	I-protein
with	with	IN	B-PP	O
regards	regard	NNS	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
prognosis	prognosis	NN	I-NP	O
,	,	,	O	O
family	family	NN	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
withdraw	withdraw	VB	I-VP	O
medical	medical	JJ	B-NP	O
care	care	NN	I-NP	O
and	and	CC	O	O
discharge	discharge	VB	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
hospice	hospice	NN	B-NP	O
services	service	NNS	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
4/18/07	4/18/07	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
after	after	IN	B-PP	O
hospice	hospice	NN	B-NP	O
services	service	NNS	I-NP	O
were	be	VBD	B-VP	O
arranged	arrange	VBN	I-VP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Were	Be	VBD	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	O
suppository	suppository	NN	I-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
6	6	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Toradol	Toradol	NN	B-NP	O
orally	orally	RB	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
4	4	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Haldol	Haldol	NN	B-NP	O
liquid	liquid	NN	I-NP	O
1	1	CD	I-NP	O
to	to	TO	I-NP	O
3	3	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-NP	O
every	every	DT	I-NP	O
4	4	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
agitation	agitation	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
everyday	everyday	RB	B-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Morphine	Morphine	NN	B-NP	O
liquid	liquid	NN	I-NP	O
5	5	CD	B-NP	O
to	to	TO	I-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
every	every	DT	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

Support	Support	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
family	family	NN	I-NP	O
was	be	VBD	B-VP	O
provided	provide	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
family	family	NN	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
call	call	VB	I-VP	O
house	house	NN	B-NP	O
officer	officer	NN	I-NP	O
on	on	IN	B-PP	O
call	call	NN	B-NP	O
if	if	IN	B-SBAR	O
any	any	DT	B-NP	O
question	question	NN	I-NP	O
might	might	MD	B-VP	O
arise	arise	VB	I-VP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
7-1379911	7-1379911	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
SPAHN	SPAHN	NN	B-NP	B-protein
,	,	,	O	O
NEWTON	NEWTON	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MUDRICK	MUDRICK	NNP	B-NP	O
,	,	,	O	O
JAMEY	JAMEY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
0562557	0562557	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
5/20/07	5/20/07	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/20/07	5/20/07	CD	B-NP	O

